MTF Biologics Executive and Leadership Team

Michael Kawas, the Senior Advisor To the Chief Financial Officer and CSO at MTF Biologics, executes financial planning and strategic oversight for the organization. Overseeing the integration of fiscal health with scientific research goals, the Senior Advisor To the Chief Financial Officer and CSO ensures that capital allocation supports the development of new orthopedics and wound care technologies. This leadership role involves evaluating the economic viability of reconstructive surgery product lines to maximize operational efficiency. By providing critical analysis to the executive team, Michael Kawas drives informed decision-making regarding resource distribution and long-term investment. The Senior Advisor To the Chief Financial Officer and CSO monitors financial performance metrics to ensure alignment with the mission of the tissue bank. Kawas manages complex budgetary processes that facilitate the expansion of clinical services. Through rigorous financial modeling, the Senior Advisor To the Chief Financial Officer and CSO secures the fiscal stability required for the company to continue providing essential biological solutions.

Marvin Furusho, the President at MTF Biologics, directs the overarching strategic vision and operational execution for the entire organization. Overseeing the diverse portfolio of allograft tissue transplant services, the President ensures that the company maintains its status as a leader in orthopedics and reconstructive surgery. This leadership role involves coordinating with the Board and C-suite to drive growth across international markets while upholding the highest standards of tissue safety. By championing innovation in wound care, Marvin Furusho directly impacts the clinical outcomes for patients worldwide. The President manages the alignment of departmental goals to ensure that the mission of the tissue bank remains the primary focus of every operational unit. Furusho facilitates high-level partnerships that expand the reach of the organization into new medical sectors. Through decisive leadership and a commitment to excellence, the President secures the future of the company as a cornerstone of the modern healthcare industry.

Bang Amrillah, the Chief Marketing Officer at MTF Biologics, directs all brand positioning and market outreach strategies for the organization. Overseeing the promotion of allograft tissue transplant services, the Chief Marketing Officer ensures that clinical partners understand the value of advanced orthopedics and wound care solutions. This leadership role involves analyzing market trends to expand the reach of reconstructive surgery products across North American healthcare systems. By aligning promotional activities with the core mission of the tissue bank, Bang Amrillah drives significant growth in service adoption. The Chief Marketing Officer manages cross-functional teams to maintain consistent messaging regarding tissue safety and quality standards. Through strategic digital campaigns and professional education initiatives, Amrillah strengthens the reputation of the company within the competitive medical landscape. This executive focus ensures that the organization remains the preferred partner for surgeons and hospitals seeking reliable, high-quality biological solutions for complex patient needs.

Maria Szydlowski, the Chief Human Resources Officer at MTF Biologics, architects the talent acquisition and organizational development frameworks necessary for a leading tissue bank. Overseeing the recruitment of specialized medical and scientific personnel, the Chief Human Resources Officer ensures that the workforce maintains the highest standards of operational excellence. This leadership role involves designing comprehensive training programs that support the complex requirements of allograft tissue processing and distribution. By fostering a culture of innovation and safety, Maria Szydlowski directly impacts the ability of the company to deliver life-changing medical products. The Chief Human Resources Officer collaborates with executive leadership to align human capital strategies with long-term corporate objectives. Szydlowski manages performance management systems that reward technical proficiency and commitment to patient care. Through the implementation of robust employee engagement initiatives, the Chief Human Resources Officer secures the retention of top-tier talent essential for maintaining the market position of the organization.